Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma

Biological Chemistry Hoppe-Seyler

Volumn 377, Issue 6, 1996, Pages 385-390

  Budihna, Marjan ^a   Strojan, Primoz ^a   Èmid, Lojze ^a   Èkrk, Janez ^a   Vrhovec, Ivan ^a   Zupevc, Avgust ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Cathepsins B, H, L, D; Head and neck carcinoma; Prognostic value; Stefins A, B

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CATHEPSIN H; CATHEPSIN L; STEFIN A; STEFIN B;

ARTICLE; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; LARYNX; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; SURVIVAL; SURVIVAL RATE;

EID: 0029823509     PISSN: 01773593     EISSN: None     Source Type: Journal    
DOI: 10.1515/bchm3.1996.377.6.385     Document Type: Article

References (23)

1. Azzopardi, J. G., Chepizk, O.P., and Hartman, W.H. (1981). International Histological Classification of Tumours No. 2: Histological typing of breast tumours. 2nd ed. (Geneva, Swiss: World Health Organization).
2. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72,248 - 254.
3. Campo, E., Munozo, J., Miquel, R., Palacin, A., Cardesa, A., Sloane, B.F., and Emmert-Buck, M.R. (1994). Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am. J. Pathol. 145,301 -309.
4. EORTC Breast Cancer Cooperative Group (1980). Revision of the standards for the assessments of hormon receptors in human breast cancer. Eur. J. Cancer 76,1513 -1515.
5. Ferrandina, G., Scambia, G., Benedetti Panici, P., Almadori, G., Paludetti, G., Cadoni, G., Distefano, M., Maurizi, M., and Mancuso, S. (1992). Cathepsin D in primary squamous laryngeal tumors: correlation with clinico-pathological parameters and receptor status. Cancer Lett. 67,133 -138.
6. Gabrijelcic, D., Svetic, B., Spaic, D., Skrk, J., Budihna, M., Dolenc, I., Popovic, T., Cotic, V., and Turk, V. (1992). Cathepsins B, H and L in human breast carcinoma. Eur. J. Clin. Chem. Clin. Biochem. 30,69-74.
7. Hermanek, P., and Sobin, L. (1987). TNM Classification of Malignant Tumours. International Union Against Cancer (UlCC). 4th ed., (Berlin, Germany: Springer-Verlag).
8. Järvinen, M., Rinne, A., and Hopsu-Havu, V.K. (1987). Human cystatins in normal and diseased tissues-a review. Acta Histochem.S2.5-18.
9. Jerala, R., Zerovnik, E., Lohner, K., and Turk, V. (1994). Structural basis for the difference in thermodynamic properties between the two cysteine proteinase inhibitors human stefins A and B. Protein Engineering 7,977- 984.
10. Kaplan, E.L., and Meier, P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53,457-481.
11. Kopitar-Jerala, N.,Curin-Serbec, V., Jerala, R., Krizaj, I., Gubensek, F., and Turk, V. (1993). Monoclonal antibodies to human stefin B and determination of their epitopes. Biochem. Biophys.Acta64,75-80.
12. Kos, J.,Smid, A., Krasevec, M., Svetic, B., Lenarcic, B., Vrhovec, I., Skrk, J., and Turk, V. (1995). Lysosomai proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer. Biol. Chem. Hoppe-Seyler376,401-405.
13. Krepela, E., Kasafirek, E., Novak, K., and Viklicky, J. (1990). Increased cathepsin B activity in human lung tumors. Neoplasma37,61-70.
14. Lah, T.T., Clifford, J.L, Helmer, K.M., Day, N.A., Moin, K., Honn, K.V., Crissman, J.D., and Sloane, B.F. (1989). Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochem. Biophys. Acta 993,63 -73.
15. Lah, T.T., Kokalj-Kunovar, M., Strukelj, B., Pungercar, J., BarlicMagajna, D., Drobnic-Kosorok, M., Kastelic, L, Babnik, J., Golouh, R., and Turk, V. (1992). Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int. J. Cancer 50, 36-44.
16. Okumichi.T, Nishiki, M.,Takasugi, S., Yamane, M., and Ezaki, H. (1984). Purification of thiol protease inhibitor from human lung cancer tissue. Hiroshima J. Med. Sei. 33,801 - 808.
17. Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J., and Smith, P.G. (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer 35,1-39.
18. Scambia, G., Panici, P.B., Ferrandina, G., Salerno, G., D'Agostino, G., Distefano, M., De Vincenzo, R., Ercoli, A., and Mancuso, S. (1994). Clinical significance of cathepsin D in primary ovarian cancer. Eur. J. Cancer 30A, 935-940.
19. Schwartz, M.K. (1995). Tissue cathepsins as tumor markers. ClinicaChimica Acta 237,67-78.
20. Sheahan, K., Shuja, S., and Murnane, M.J. (1989). Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res. 49,3809 - 3814.
21. Sloane, B.F., Moin, K., and Lah, T.T. (1994). Regulation of lysosomal endopeptidases in malignant neoplasia. In: Biochemical and Molecular Aspects of Selected Cancers, Vol. II, T.G. Pretlow and T.P. Pretlow, eds. (New York, USA: Academic Press), pp. 411-472.
22. Watanabe, M., Higashi, T., Hashimoto, M., Tomoda, I., Tominaga, S., Hashimoto, N., Morimoto, S., Yamauchi, Y., Nakatsukasa, H., Kobayashi, M., Watanabe, A., and Nagashima, H. (1987). Elevation of tissue cathepsin B and L activités in gastric cancer. Hepato-gastroenterol. 34,120-122.
23. Zeillinger, R., Swoboda, H., Machacek, E., Nekahm, D., Sliutz, G., Knogler, W., Speiser, P., Swoboda, E., and Kubista, E. (1992). Expression of cathepsin D in head and neck cancer. Eur. J. Cancer 28A, 1413-1415.